52012XC1130(08)

Language
- My EUR-Lex
- Sign in
- Register
- My recent searches (0)

This document is an excerpt from the EUR-Lex website

Search tips

Need more search options? Use the Advanced search

EUROPA
EUR-Lex home
EUR-Lex - 52012XC1130(08) - EN

Document 52012XC1130(08)

Help

Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 October 2012 to 31 October 2012 (Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council )

OJ C 371, 30.11.2012, p. 7–25 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

HTML

PDF

Official Journal

30.11.2012

Official Journal of the European Union

C 371/7

Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 October 2012 to 31 October 2012

(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council (1) )

2012/C 371/03

— Issuing of a marketing authorization (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted

Date of the decision

Name of the medicinal product

INN (International Non-Proprietary Name)

Holder of the marketing authorization

Number of the entry in the Community Register

Pharmaceutical form

ATC code (Anatomical Therapeutic Chemical Code)

Date of notification

23.10.2012

XALKORI

crizotinib

Pfizer Limited

Ramsgate Road, Sandwich, Kent CT13 9NJ United Kingdom

EU/1/12/793/001-004

Capsule, hard

L01XE16

26.10.2012

25.10.2012

Adcetris

Brentuximab vedotin

Takeda Global Research and Development Centre (Europe) Ltd.

61 Aldwych, London WC2B 4AE, United Kingdom

EU/1/12/794/001

powder for concentrate for solution for infusion

L01XC12

30.10.2012

25.10.2012

Glybera

Alipogene tiparvovec

uniQure biopharma B.V.

Meibergdreef 61, 1105 BA Amsterdam, Nederland

EU/1/12/791/001

Solution for injection

C10AX10

29.10.2012

— Issuing of a marketing authorization (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Rejected

Date of the decision

Name of the medicinal product

Holder of the marketing authorization

Number of the entry in the Community Register

Date of notification

25.10.2012

Elelyso

Pfizer Limited

Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom

—

29.10.2012

— Modification of a marketing authorization (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted

Date of the decision

Name of the medicinal product

Holder of the marketing authorization

Number of the entry in the Community Register

Date of notification

1.10.2012

Cialis

Eli Lilly Nederland B.V.

Grootslag 1-5, 3991 RA Houten, Nederland

EU/1/02/237/001-009

3.10.2012

1.10.2012

Conbriza

Pfizer Limited

Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom

EU/1/09/511/001-005

3.10.2012

1.10.2012

Olanzapine Neopharma

Neopharma Limited

57 High Street, Odiham, Hampshire RG29 1LF, United Kingdom

EU/1/07/426/001-011

3.10.2012

1.10.2012

Tamiflu

Roche Registration Limited

6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom

EU/1/02/222/001-005

3.10.2012

4.10.2012

Cimzia

UCB Pharma SA.

Allée de la Recherche 60, 1070 Bruxelles, Belgique/Researchdreef, 60, Brussel 1070, België

EU/1/09/544/001-002

8.10.2012

4.10.2012

Orencia

Bristol-Myers Squibb Pharma EEIG

Uxbridge Business Park, Sanderson Road, Uxbridge UB8 1DH, United Kingdom

EU/1/07/389/001-009

8.10.2012

4.10.2012

Soliris

Alexion Europe S.A.S.

25, boulevard de l'Amiral Bruix, 75016 Paris, France

EU/1/07/393/001

8.10.2012

4.10.2012

Topotecan Eagle

Eagle Laboratories Limited

The Clock House, Station Approach, Marlow, Bucks SL7 1NT, UNITED KINGDOM

EU/1/11/744/002

8.10.2012

4.10.2012

Vepacel

Baxter Innovations GmbH

Industriestrasse 67, A – 1221 Vienna, Österreich

EU/1/12/752/001-002

8.10.2012

Biograstim

CT Arzneimittel GmbH

Graf-Arco-Strasse 3, 89079 Ulm, Deutschland

EU/1/08/450/001-010

11.10.2012

8.10.2012

Comtan

Novartis Europharm Ltd

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/98/081/001-004

10.10.2012

8.10.2012

DuoTrav

Alcon Laboratories (UK) Ltd.

Pentagon Park, Boundary Way, Hemel Hempstead, Herts HP2 7UD, United Kingdom

EU/1/06/338/001-003

10.10.2012

8.10.2012

Vidaza

Celgene Europe Ltd

1 Longwalk Road, Stockley Park, Uxbridge, UB11 1DB, United Kingdom

EU/1/08/488/001

10.10.2012

8.10.2012

Zavesca

Actelion Registration Ltd.

Cheswick Tower, 13th floor, 389 Cheswick High Road, London W4 4AL, United Kingdom

EU/1/02/238/001

10.10.2012

Aprovel

Sanofi Pharma Bristol-Myers Squibb SNC

54, rue La Boétie, 75008 Paris, France

EU/1/97/046/001-039

12.10.2012

10.10.2012

Biopoin

CT Arzneimittel GmbH

Graf-Arco-Strasse 3, 89079 Ulm, Deutschland

EU/1/09/565/001-028

12.10.2012

10.10.2012

Dynastat

Pfizer Ltd

Ramsgate Road, Sandwich, Kent CT 13 9NJ, United Kingdom

EU/1/02/209/001-008

12.10.2012

10.10.2012

Emend

Merck Sharp & Dohme Ltd

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/03/262/001-010

15.10.2012

10.10.2012

Karvea

Bristol-Myers Squibb Pharma EEIG

Uxbridge Business Park, Sanderson Road, Uxbridge UB8 1DH, United Kingdom

EU/1/97/049/034-039

12.10.2012

10.10.2012

Pylobactell

Torbet Laboratories Limited

Unit 14D, Wendover Road, Rackheath Industrial Estate, Norwich, Norfolk NR13 6LH, United Kingdom

EU/1/98/064/001

12.10.2012

10.10.2012

Rapamune

Pfizer Limited

Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom

EU/1/01/171/007-010

12.10.2012

10.10.2012

Synagis

AbbVie Ltd.

Maidenhead, SL6 4XE, United Kingdom

EU/1/99/117/001-002

12.10.2012

15.10.2012

Ceplene

Meda AB

Box 906, SE 170 09 Solna, Sverige

EU/1/08/477/001

17.10.2012

15.10.2012

Clopidogrel Apotex

Apotex Europe B.V.

Darwingweg 20, 2333 CR Leiden, Nederland

EU/1/09/568/001-018

17.10.2012

15.10.2012

Olazax

Glenmark Pharmaceuticals s.r.o.

City Tower, Hvězdova 1716/2b, 140 78 Praha 4, Česká republika

EU/1/09/597/001-005

16.10.2012

23.10.2012

Alimta

Eli Lilly Nederland B.V.

Grootslag 1-5, 3991 RA Houten, Nederland

EU/1/04/290/001-002

26.10.2012

23.10.2012

Glivec

Novartis Europharm Ltd

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/01/198/001-013

26.10.2012

23.10.2012

Helixate NexGen

Bayer Schering Pharma AG

13342 Berlin, Deutschland

EU/1/00/144/001-005

26.10.2012

23.10.2012

Humira

AbbVie Ltd.

Maidenhead, SL6 4XE, United Kingdom

EU/1/03/256/001-010

26.10.2012

23.10.2012

Kogenate Bayer

Bayer Pharma AG

13342 Berlin, Deutschland

EU/1/00/143/004-013

26.10.2012

23.10.2012

Nplate

Amgen Europe B.V.

Minervum 7061, 4817 ZK Breda, Nederland

EU/1/08/497/001-008

26.10.2012

23.10.2012

NULOJIX

Bristol-Myers Squibb Pharma EEIG

Uxbridge Business Park, Sanderson Road, Uxbridge UB8 1DH, United Kingdom

EU/1/11/694/001-002

26.10.2012

23.10.2012

Osseor

Les Laboratoires Servier

50, rue Carnot, 92284 Suresnes cedex, France

EU/1/04/287/001-006

26.10.2012

23.10.2012

Prolia

Amgen Europe B.V.

Minervum 7061, NL-4817 ZK Breda, Nederland

EU/1/10/618/001-004

26.10.2012

23.10.2012

Protelos

Les Laboratoires Servier

50, rue Carnot, 92284 Suresnes cedex, France

EU/1/04/288/001-006

26.10.2012

23.10.2012

Telzir

ViiV Healthcare UK Ltd

980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom

EU/1/04/282/001-002

26.10.2012

23.10.2012

Victoza

Novo Nordisk A/S

Novo Allé, DK-2880 Bagsvaerd, Danmark

EU/1/09/529/001-005

26.10.2012

23.10.2012

Visudyne

Novartis Europharm Ltd

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/00/140/001

26.10.2012

24.10.2012

Adenuric

Menarini International Operations Luxembourg S.A.

1, Avenue de la Gare, L-1611 Luxembourg, Luxembourg

EU/1/08/447/001-012

26.10.2012

24.10.2012

Avastin

Roche Registration Limited

6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom

EU/1/04/300/001-002

26.10.2012

24.10.2012

Baraclude

Bristol-Myers Squibb Pharma EEIG

Uxbridge Business Park, Sanderson Road, Uxbridge UB8 1DH, United Kingdom

EU/1/06/343/001-007

26.10.2012

24.10.2012

Benlysta

Glaxo Group Limited

Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex UB6 0NN, United Kingdom

EU/1/11/700/001-002

26.10.2012

24.10.2012

Brilique

AstraZeneca AB

Södertälje S 151 85, Sverige

EU/1/10/655/001-006

26.10.2012

24.10.2012

ChondroCelect

TiGenix NV

Romeinse straat 12/2, B-3001 LEUVEN, België

EU/1/09/563/001

26.10.2012

24.10.2012

Cialis

Eli Lilly Nederland B.V.

Grootslag 1-5, 3991 RA Houten, Nederland

EU/1/02/237/007-008

26.10.2012

24.10.2012

Clopidogrel HCS

HCS bvba

H. Kennisstraat 53, B 2650 Edegem, Belgïe

EU/1/10/651/001-015

26.10.2012

24.10.2012

Daliresp

Nycomed GmbH

Byk-Gulden-Str. 2, D-78467 Konstanz, Deutschland

EU/1/11/668/001-003

26.10.2012

24.10.2012

Daxas

Nycomed GmbH

Byk-Gulden-Str. 2, D-78467 Konstanz, Deutschland

EU/1/10/636/001-007

26.10.2012

24.10.2012

Dynastat

Pfizer Ltd

Ramsgate Road, Sandwich, Kent CT 13 9NJ, United Kingdom

EU/1/02/209/005-008

26.10.2012

24.10.2012

EDURANT

Janssen-Cilag International NV

Turnhoutseweg 30, B-2340 Beerse, België

EU/1/11/736/001

26.10.2012

24.10.2012

Enbrel

Pfizer Limited

Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom

EU/1/99/126/001-022

26.10.2012

24.10.2012

Eviplera

Gilead Sciences International Limited

Cambridge, CB21 6GT, United Kingdom

EU/1/11/737/001-002

26.10.2012

24.10.2012

Exjade

Novartis Europharm Ltd

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/06/356/001-009

26.10.2012

24.10.2012

Ganfort

Allergan Pharmaceuticals Ireland

Castlebar Road, Westport, Co. Mayo, Ireland

EU/1/06/340/001-002

26.10.2012

24.10.2012

Humira

AbbVie Ltd.

Maidenhead, SL6 4XE, United Kingdom

EU/1/03/256/001-010

26.10.2012

24.10.2012

Invirase

Roche Registration Limited

6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom

EU/1/96/026/001-002

26.10.2012

24.10.2012

Kinzalkomb

Bayer Pharma AG

Berlin 13342, Deutschland

EU/1/02/214/001-015

26.10.2012

24.10.2012

Komboglyze

Bristol Myers Squibb/AstraZeneca EEIG

Bristol Myers Squibb House, Uxbridge Business Park, Sanderson Road, Uxbridge, Middlesex UB8 1DH, United Kingdom

EU/1/11/731/001-014

26.10.2012

24.10.2012

Libertek

Nycomed GmbH

Byk-Gulden-Str. 2, D-78467 Konstanz, Deutschland

EU/1/11/666/001-003

26.10.2012

24.10.2012

MicardisPlus

Boehringer Ingelheim International GmbH

Binger Strasse 173- D - 55216 Ingelheim am Rhein, Deutschland

EU/1/02/213/001-023

26.10.2012

24.10.2012

Multaq

Sanofi

54, rue La Boétie, 75008 Paris, France

EU/1/09/591/001-004

26.10.2012

24.10.2012

Norvir

AbbVie Ltd.

Maidenhead, SL6 4XE, United Kingdom

EU/1/96/016/001

EU/1/96/016/003-008

26.10.2012

24.10.2012

NovoSeven

Novo Nordisk A/S

Novo Allé, DK-2880 Bagsvaerd, Danmark

EU/1/96/006/001-011

26.10.2012

24.10.2012

Onduarp

Boehringer Ingelheim International GmbH

Binger Str. 173, D-55216 Ingelheim am Rhein, Deutschland

EU/1/11/729/001-006

26.10.2012

24.10.2012

Pandemrix

GlaxoSmithKline Biologicals S.A.

rue de l'Institut 89, Rixensart, B-1330 Belgique

EU/1/08/452/001

26.10.2012

24.10.2012

Possia

AstraZeneca AB

Södertälje S 151 85, Sverige

EU/1/10/656/001-006

26.10.2012

24.10.2012

PREZISTA

Janssen-Cilag International NV

Turnhoutseweg 30, B - 2340 Beerse, België

EU/1/06/380/001-006

26.10.2012

24.10.2012

PritorPlus

Bayer Pharma AG

13342 Berlin, Deutschland

EU/1/02/215/001-021

26.10.2012

24.10.2012

ReFacto AF

Pfizer Limited

Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom

EU/1/99/103/001-009

26.10.2012

24.10.2012

RotaTeq

Sanofi Pasteur MSD, SNC

8, rue Jonas Salk, Lyon 69007, France

EU/1/06/348/001-002

26.10.2012

24.10.2012

SonoVue

Bracco International B.V.

Strawinskylaan 3051, 1077 ZX Amsterdam, Nederland

EU/1/01/177/002

26.10.2012

24.10.2012

Thymanax

Servier (Ireland) Industries Limited

Gorey Road, Arklow, Co. Wicklow, Ireland

EU/1/08/498/001-008

26.10.2012

24.10.2012

Trajenta

Boehringer Ingelheim International GmbH

Binger Strasse 173- D - 55216 Ingelheim am Rhein, Deutschland

EU/1/11/707/001-011

26.10.2012

24.10.2012

Valdoxan

Les Laboratoires Servier

50, rue Carnot, 92284 Suresnes cedex, France

EU/1/08/499/001-008

26.10.2012

24.10.2012

Vimpat

UCB Pharma SA.

Allée de la Recherche 60, 1070 Bruxelles, Belgique/Researchdreef, 60, Brussel 1070, België

EU/1/08/470/001-013

EU/1/08/470/016-019

29.10.2012

24.10.2012

Votrient

Glaxo Group Limited

Berkeley Avenue, Greenford, Middlesex UB6 0NN, United Kingdom

EU/1/10/628/001-004

26.10.2012

24.10.2012

Zometa

Novartis Europharm Ltd

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/01/176/001-009

26.10.2012

25.10.2012

Bridion

N.V. Organon

Kloosterstraat 6, 5349 AB Oss, Nederland

EU/1/08/466/001-002

29.10.2012

25.10.2012

Capecitabine Krka

KRKA, d.d

Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenija

EU/1/12/763/001-018

30.10.2012

25.10.2012

Cinryze

ViroPharma SPRL-BVBA

rue Montoyer 47, 1000 Bruxelles, Belgique/Montoyerstraat 47, 1000 Brussel, België

EU/1/11/688/001

29.10.2012

25.10.2012

Clopidogrel Teva Pharma

Teva Pharma B.V.

Computerweg 10, 3542 DR Utrecht, Nederland

EU/1/09/561/001-011

29.10.2012

25.10.2012

Copalia

Novartis Europharm Ltd

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/06/372/001-039

29.10.2012

25.10.2012

Corlentor

Les Laboratoires Servier

50 rue Carnot, 92284 Suresnes, Cedex, France

EU/1/05/317/001-014

29.10.2012

25.10.2012

Dafiro

Novartis Europharm Ltd

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/06/371/001-039

29.10.2012

25.10.2012

Efavirenz Teva

Teva Pharma BV

Computerweg 10, 3542 DR Utrecht, Nederland

EU/1/11/742/001-010

30.10.2012

25.10.2012

Eucreas

Novartis Europharm Ltd

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/07/425/001-018

29.10.2012

25.10.2012

Exforge HCT

Novartis Europharm Ltd

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/09/569/001-060

29.10.2012

25.10.2012

Fasturtec

Sanofi-aventis groupe

54, rue La Boétie, 75008 Paris, France

EU/1/00/170/001-002

26.10.2012

25.10.2012

Ferriprox

Apotex Europe B.V.

Darwingweg 20, 2333 CR Leiden, Nederland

EU/1/99/108/001-006

29.10.2012

25.10.2012

Firazyr

Shire Orphan Therapies GmbH

Friedrichstrasse 149, D-10117 Berlin, Deutschland

EU/1/08/461/001-002

29.10.2012

25.10.2012

Glidipion

Actavis Group PTC ehf.

Reykjavíkurvegi 76 - 78, 220 Hafnarfjörður, Iceland

EU/1/12/756/001-027

29.10.2012

25.10.2012

Helicobacter test INFAI

INFAI, Institut für biomedizinische Analytik & NMR Imaging GmbH

Universitätsstrasse 142, D - 44799 Bochum, Deutschland

EU/1/97/045/001-005

29.10.2012

25.10.2012

Humalog

Eli Lilly Nederland B.V.

Grootslag 1-5, 3991 RA Houten, Nederland

EU/1/96/007/002

EU/1/96/007/004-006

EU/1/96/007/008

EU/1/96/007/010

EU/1/96/007/015-021

EU/1/96/007/023-038

30.10.2012

25.10.2012

Incivo

Janssen-Cilag International NV

Turnhoutseweg 30, B-2340 Beerse, België

EU/1/11/720/001-002

29.10.2012

25.10.2012

Instanyl

Nycomed Danmark ApS

Langebjerg 1, DK-4000 Roskilde, Danmark

EU/1/09/531/001-021

29.10.2012

25.10.2012

Irbesartan Teva

Teva Pharma B.V.

Computerweg 10, 3542 DR Utrecht, Nederland

EU/1/09/576/001-042

30.10.2012

25.10.2012

Isentress

Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/07/436/001-002

30.10.2012

25.10.2012

Jentadueto

Boehringer Ingelheim International GmbH

Binger Str. 173, D-55216 Ingelheim am Rhein, Deutschland

EU/1/12/780/029-034

30.10.2012

25.10.2012

Kaletra

AbbVie Ltd.

Maidenhead, SL6 4XE, United Kingdom

EU/1/01/172/001-008

30.10.2012

25.10.2012

Kepivance

Swedish Orphan Biovitrum AB (publ)

SE-112 76, Stockholm, Sverige

EU/1/05/314/001

29.10.2012

25.10.2012

Kineret

Swedish Orphan Biovitrum AB (publ)

SE-112 76, Stockholm, Sverige

EU/1/02/203/001-004

30.10.2012

25.10.2012

Liprolog

Eli Lilly Nederland B.V.

Grootslag 1-5, 3991 RA Houten, Nederland

EU/1/01/195/001-027

29.10.2012

25.10.2012

Olanzapine Glenmark

Glenmark Generics (Europe) Limited

Laxmi House, 2-B Draycott Avenue, Kenton, Harrow, Middlesex HA3 OBU, United Kingdom

EU/1/09/587/001-017

29.10.2012

25.10.2012

Olanzapine Glenmark Europe

Glenmark Generics (Europe) Limited

Laxmi House, 2-B Draycott Avenue, Kenton, Harrow, Middlesex HA3 OBU, United Kingdom

EU/1/09/588/001-012

29.10.2012

25.10.2012

Olanzapine Mylan

Generics [UK] Limited

Station Close, Potters Bar, Hertfordshire, EN6 1TL, United Kingdom

EU/1/08/475/001-060

29.10.2012

25.10.2012

Olazax Disperzi

Glenmark Pharmaceuticals s.r.o.

City Tower, Hvězdova 1716/2b, 140 78 Praha 4, Česká republika

EU/1/09/592/001-005

29.10.2012

25.10.2012

Procoralan

Les Laboratoires Servier

50, rue Carnot, 92284 Suresnes cedex, France

EU/1/05/316/001-014

29.10.2012

25.10.2012

Ranexa

Menarini International Operations Luxembourg S.A.

1, Avenue de la Gare, L-1611 Luxembourg, Luxembourg

EU/1/08/462/001-012

30.10.2012

25.10.2012

Synflorix

GlaxoSmithKline Biologicals S.A.

rue de l'Institut 89, 1330 Rixensart, Belgique

EU/1/09/508/001-011

29.10.2012

25.10.2012

Temomedac

medac Gesellschaft für klinische Spezialpräparate mbH

Fehlandtstrasse 3, D-20354 Hamburg - Deutschland

EU/1/09/605/001-012

29.10.2012

25.10.2012

Temozolomide HEXAL

HEXAL AG

Industriestrasse 25, D-83607 Holzkirchen, Deutschland

EU/1/10/616/001-002

EU/1/10/616/005-006

EU/1/10/616/009-010

EU/1/10/616/013-014

EU/1/10/616/017-018

EU/1/10/616/021-022

EU/1/10/616/025-036

30.10.2012

25.10.2012

Temozolomide Sandoz

Sandoz Pharmaceuticals GmbH

Raiffeisenstraße 11, 83607 Holzkirchen, Deutschland

EU/1/10/617/001-002

EU/1/10/617/005-006

EU/1/10/617/009-010

EU/1/10/617/013-014

EU/1/10/617/017-018

EU/1/10/617/021-022

EU/1/10/617/025-036

30.10.2012

25.10.2012

Temozolomide SUN

Sun Pharmaceuticals Industries Europe B.V.

Polarisavenue 87, 2132 JH Hoofddorp, Nederland

EU/1/11/697/001-024

30.10.2012

25.10.2012

Temozolomide Teva

Teva Pharma B.V.

Computerweg 10, DR Utrecht 3542, Nederland

EU/1/09/606/001-012

29.10.2012

25.10.2012

Topotecan Teva

Teva Pharma B.V.

Computerweg 10, DR Utrecht 3542, Nederland

EU/1/09/552/001-004

29.10.2012

25.10.2012

Toviaz

Pfizer Limited

Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom

EU/1/07/386/019-020

29.10.2012

25.10.2012

Tracleer

Actelion Registration Ltd

Chiswick Tower 13th Floor, 389 Chiswick High Road, London W4 4AL, United Kingdom

EU/1/02/220/001-006

30.10.2012

25.10.2012

Tredaptive

Merck Sharp & Dohme Ltd

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/08/459/001-014

29.10.2012

25.10.2012

Trevaclyn

Merck Sharp & Dohme Ltd

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/08/458/001-014

29.10.2012

25.10.2012

Twynsta

Boehringer Ingelheim International GmbH

Binger Strasse 173 - D - 55216 Ingelheim am Rhein, Deutschland

EU/1/10/648/001-028

29.10.2012

25.10.2012

Vectibix

Amgen Europe B.V.

Minervum 7061, NL-4817 ZK Breda, Nederland

EU/1/07/423/001-003

29.10.2012

Advagraf

Astellas Pharma Europe B.V.

Elisabethhof 19, NL-2353 EW Leiderdorp, Nederland

EU/1/07/387/009-010

EU/1/07/387/016

EU/1/07/387/026

1.11.2012

29.10.2012

Aranesp

Amgen Europe B.V.

Minervum 7061, NL-4817 ZK Breda, Nederland

EU/1/01/185/001-022

EU/1/01/185/031-111

1.11.2012

29.10.2012

ATryn

GTC Biotherapeutics UK Limited

10 Norwich Street, London EC4A 1BD, United Kingdom

EU/1/06/355/001-003

6.11.2012

29.10.2012

Biograstim

CT Arzneimittel GmbH

Graf-Arco-Strasse 3, 89079 Ulm, Deutschland

EU/1/08/450/001-010

5.11.2012

29.10.2012

Bronchitol

Pharmaxis Pharmaceuticals Limited

The Priory, Stomp Road, Burnham, Buckinghamshire, SL1 7LW, United Kingdom

EU/1/12/760/001-002

1.11.2012

29.10.2012

Byetta

Eli Lilly Nederland B.V.

Grootslag 1-5, 3991 RA Houten, Nederland

EU/1/06/362/001-004

1.11.2012

29.10.2012

Caelyx

Janssen-Cilag International NV

Turnhoutseweg 30, B-2340 Beerse, België

EU/1/96/011/001-004

5.11.2012

29.10.2012

CANCIDAS

Merck Sharp & Dohme Ltd

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/01/196/001

EU/1/01/196/003

6.11.2012

29.10.2012

Dificlir

Astellas Pharma Europe B.V.

Elisabethhof 19, 2353 EW Leiderdorp, Nederland

EU/1/11/733/001-004

31.10.2012

29.10.2012

Docetaxel Mylan

Mylan S.A.S

117 allée des Parcs, 69 800 Saint Priest, France

EU/1/11/748/001-006

6.11.2012

29.10.2012

Esbriet

InterMune UK Ltd

Euston Tower, Floor 32, 286 Euston Road, London, NW1 3DP, United Kingdom

EU/1/11/667/001-004

1.11.2012

29.10.2012

Exforge

Novartis Europharm Ltd

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/06/370/001-039

31.10.2012

29.10.2012

Firdapse

BioMarin Europe Ltd

164 Shaftesbury Avenue, London WC2H 8HL, United Kingdom

EU/1/09/601/001

1.11.2012

29.10.2012

Foscan

Biolitec pharma Ltd

United Drug House, Magna Drive, Dublin 24, Ireland

EU/1/01/197/001-002

31.10.2012

29.10.2012

Fycompa

Eisai Europe Limited

European Knowledge Centre, Mosquito Way, Hatfield, Hertsforshire AL10 9SN, United Kingdom

EU/1/12/776/001-023

31.10.2012

29.10.2012

Ibandronic Acid Teva

Teva Pharma B.V.

Computerweg 10, 3542 DR Utrecht, Nederland

EU/1/10/642/001-004

31.10.2012

29.10.2012

Icandra

Novartis Europharm Ltd

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/08/484/001-018

1.11.2012

29.10.2012

Imprida

Novartis Europharm Ltd

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/06/373/001-039

31.10.2012

29.10.2012

INOmax

INO Therapeutics AB

SE-181 81 Lidingö, Sverige

EU/1/01/194/001-004

1.11.2012

29.10.2012

Irbesartan/Hydrochlorothiazide Teva

Teva Pharma B.V.

Computerweg 10, 3542 DR Utrecht, Nederland

EU/1/09/583/001-075

1.11.2012

29.10.2012

Javlor

Pierre Fabre Médicament

45, place Abel Gance, F-92100 Boulogne, France

EU/1/09/550/001-012

31.10.2012

29.10.2012

Leflunomide Teva

Teva Pharma B.V.

Computerweg 10, 3542 DR Utrecht, Nederland

EU/1/11/675/001-010

6.11.2012

29.10.2012

Levetiracetam Actavis Group

Actavis Group PTC ehf.

ReykjavÍkurvegur 76-78, Hafnarfjörður 220, Iceland

EU/1/11/738/001-003

1.11.2012

29.10.2012

Lucentis

Novartis Europharm Ltd

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/06/374/001

1.11.2012

29.10.2012

Myclausen

Herbert J. Passauer GmbH & Co. KG

Stubenrauchstrasse 33, 14167 Berlin, Deutschland

EU/1/10/647/001-004

31.10.2012

29.10.2012

Myocet

Cephalon Europe

5 Rue Charles Martigny, Maisons Alfort 94700, France

EU/1/00/141/001-002

5.11.2012

29.10.2012

Nimvastid

KRKA, d.d., Novo mesto

Šmarješka cesta 6, 8501 Novo mesto, Slovenija

EU/1/09/525/001-050

5.11.2012

29.10.2012

Pelzont

Merck Sharp & Dohme Ltd

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/08/460/001-014

31.10.2012

29.10.2012

Pixuvri

CTI Life Sciences Ltd

Biopark, Broadwater Road, Welwyn Garden City, Hertfordshire AL73AX, United Kingdom

EU/1/12/764/001

6.11.2012

29.10.2012

Plavix

Sanofi Pharma Bristol-Myers Squibb SNC

54, rue La Boétie, 75008 Paris, France

EU/1/98/069/001a-001b

EU/1/98/069/002a-002b

EU/1/98/069/003a-003b

EU/1/98/069/004a-004b

EU/1/98/069/005a-005b

EU/1/98/069/006a-006b

EU/1/98/069/007a-007b

EU/1/98/069/008-010

EU/1/98/069/011a-011b

EU/1/98/069/012

2.11.2012

29.10.2012

Plenadren

ViroPharma SPRL

Rue Montoyer 47, 1000 Bruxelles/Brussel, Belgique/België

EU/1/11/715/001-002

6.11.2012

29.10.2012

Pravafenix

LABORATOIRES SMB SA

26-28 rue de la Pastorale, 1080 Bruxelles, Belgique/26-28 Herdersliedstraat, 1080 Brussel, België

EU/1/11/679/007

6.11.2012

29.10.2012

Pumarix

GlaxoSmithKline Biologicals S.A.

rue de l'Institut 89, Rixensart, B-1330 Belgique

EU/1/10/664/001

6.11.2012

29.10.2012

Raloxifene Teva

Teva Pharma B.V.

Computerweg 10, 3542 DR Utrecht, Nederland

EU/1/10/627/001-003

6.11.2012

29.10.2012

Ranexa

Menarini International Operations Luxembourg S.A.

1, Avenue de la Gare, L-1611 Luxembourg, Luxembourg

EU/1/08/462/001-012

2.11.2012

29.10.2012

Rapiscan

Rapidscan Pharma Solutions EU Ltd.

Regent's Place, 338 Euston Road, London NW1 3BT, UK

EU/1/10/643/001

6.11.2012

29.10.2012

Repaglinide Krka

KRKA, d. d., Novo mesto

Šmarješka cesta 6, 8501 Novo mesto, Slovenija

EU/1/09/579/001-018

5.11.2012

29.10.2012

Repaglinide Teva

Teva Pharma B.V.

Computerweg 10, 3542 DR Utrecht, Nederland

EU/1/09/530/001-015

6.11.2012

29.10.2012

Repso

Teva Pharma B.V.

Computerweg 10, 3542 DR Utrecht, Nederland

EU/1/11/674/001-010

1.11.2012

29.10.2012

Ribavirin Mylan

Generics [UK] Limited

Station Close, Potters Bar, Hertfordshire, EN6 1TL, United Kingdom

EU/1/10/634/001-011

1.11.2012

29.10.2012

Rienso

Takeda Global Research and Development Centre (Europe) Ltd

61 Aldwych, London WC2B 4AE, United Kingdom

EU/1/12/774/001-004

31.10.2012

29.10.2012

Sabervel

Pharmathen S.A.

6 Dervenakion, 15351 Pallini Attiki, Ελλάδα

EU/1/12/765/001-009

31.10.2012

29.10.2012

Samsca

Otsuka Pharmaceutical Europe Ltd

Hunton House, Highbridge Business Park, Oxford Road, Uxbridge, Middlesex UB8 1LX, United Kingdom

EU/1/09/539/001-004

31.10.2012

29.10.2012

Stelara

Janssen-Cilag International NV

Turnhoutseweg 30, B - 2340 Beerse, België

EU/1/08/494/001-002

5.11.2012

29.10.2012

Sycrest

N.V. Organon

Kloosterstraat 6, 5349 AB Oss, Nederland

EU/1/10/640/001-006

6.11.2012

29.10.2012

Tasmar

Meda AB

Pipers väg 2A, SE-170 73 Solna, Sverige

EU/1/97/044/001-009

1.11.2012

29.10.2012

Telmisartan Actavis

Actavis Group PTC ehf.

Reykjavíkurvegi 76 78, 220 Hafnarfjörður, Iceland

EU/1/10/639/001-030

31.10.2012

29.10.2012

Telmisartan Teva

Teva Pharma B.V.

Computerweg 10, 3542 DR Utrecht, Nederland

EU/1/09/610/001-062

31.10.2012

29.10.2012

Telmisartan Teva Pharma

Teva Pharma B.V.

Computerweg 10, 3542 DR Utrecht, Nederland

EU/1/11/719/001-062

31.10.2012

29.10.2012

Teysuno

Nordic Group BV

Siriusdreef 22, 2132 WT Hoofddorp, Nederland

EU/1/11/669/001-005

6.11.2012

29.10.2012

Topotecan Hospira

Hospira UK Limited

Queensway, Royal Leamington Spa, Warwickshire CV31 3RW, United Kingdom

EU/1/10/633/001-002

31.10.2012

29.10.2012

Vfend

Pfizer Ltd

Ramsgate Road, Sandwich, Kent CT 13 9NJ, United Kingdom

EU/1/02/212/001-027

1.11.2012

29.10.2012

Xarelto

Bayer Pharma AG

13342 Berlin, Deutschland

EU/1/08/472/011-021

31.10.2012

29.10.2012

Zalasta

KRKA, d.d., Novo mesto

Šmarješka cesta 6, 8501 Novo mesto, Slovenija

EU/1/07/415/001-056

6.11.2012

29.10.2012

Zomarist

Novartis Europharm Ltd

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/08/483/001-018

1.11.2012

31.10.2012

Adjupanrix

GlaxoSmithKline Biologicals S.A.

Rue de l'Institut 89, 1330 Rixensart, Belgique

EU/1/09/578/001

6.11.2012

31.10.2012

Axura

Merz Pharmaceuticals GmbH

Eckenheimer Landstr. 100, D-60318 Frankfurt/Main - Deutschland

EU/1/02/218/001-003

EU/1/02/218/005-030

6.11.2012

31.10.2012

Copalia HCT

Novartis Europharm Ltd

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/09/575/001-060

6.11.2012

31.10.2012

Dafiro HCT

Novartis Europharm Ltd

Wimblehurst Road, Horsham, West Sussex RH12 5AB, United Kingdom

EU/1/09/574/001-060

6.11.2012

31.10.2012

Docetaxel Winthrop

Aventis Pharma S.A.

20 avenue Raymond Aron, F-92165 Antony Cedex, France

EU/1/07/384/003-005

6.11.2012

31.10.2012

Ebixa

H. Lundbeck A/S

Ottiliavej 9, DK-2500 Valby, Danmark

EU/1/02/219/001-003

EU/1/02/219/005-049

6.11.2012

31.10.2012

Ifirmasta

KRKA, d.d., Novo mesto

Šmarješka cesta 6, 8501 Novo mesto, Slovenija

EU/1/08/480/001-024

6.11.2012

31.10.2012

Kaletra

AbbVie Ltd.

Maidenhead, SL6 4XE, United Kingdom

EU/1/01/172/001-008

6.11.2012

31.10.2012

Kiovig

Baxter AG

Industriestraße 67, A - 1221 Wien, Österreich

EU/1/05/329/001-006

6.11.2012

31.10.2012

Levetiracetam Accord

Accord Healthcare Limited

5th Floor Charles House, 108/110 Finchley road, London NW3 5JJ, United Kingdom

EU/1/11/712/001-040

6.11.2012

31.10.2012

Levetiracetam Actavis

Actavis Group PTC ehf.

Reykjavikurvegur 76-78, 220 Hafnarfjordur, Iceland

EU/1/11/713/001-040

6.11.2012

31.10.2012

Ratiograstim

ratiopharm GmbH

Graf-Arco-Straße 3, D-89079 Ulm, Deutschland

EU/1/08/444/001-012

7.11.2012

31.10.2012

Repaglinide Accord

Accord Healthcare Limited

Sage house, 319 Pinner road, North Harrow, Middlesex HA1 4HF United Kingdom

EU/1/11/743/001-015

6.11.2012

31.10.2012

Rivastigmine Sandoz

Sandoz Pharmaceuticals GmbH

Raiffeisenstraße 11, 83607 Holzkirchen, Deutschland

EU/1/09/599/001-018

6.11.2012

31.10.2012

Siklos

ADDMEDICA

101, rue Saint Lazare, Paris 75009, France

EU/1/07/397/001-004

6.11.2012

31.10.2012

Tevagrastim

Teva GmbH

Graf-Arco-Straße 3, 89079 Ulm, Deutschland

EU/1/08/445/001-014

6.11.2012

31.10.2012

Tolura

KRKA, d.d., Novo mesto

Šmarješka cesta 6, 8501 Novo mesto, Slovenija

EU/1/10/632/001-021

6.11.2012

31.10.2012

Votubia

Novartis Europharm Limited

Wimblehurst Road, Horsham, West Sussex, RH12 5AB, United Kingdom

EU/1/11/710/001-007

6.11.2012

— Modification of a marketing authorization (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Rejected

Date of the decision

Name of the medicinal product

Holder of the marketing authorization

Number of the entry in the Community Register

Date of notification

4.10.2012

Daliresp

Nycomed GmbH

Byk-Gulden-Str. 2, D-78467 Konstanz, Deutschland

—

8.10.2012

4.10.2012

Daxas

Nycomed GmbH

Byk-Gulden-Str. 2, D-78467 Konstanz, Deutschland

—

8.10.2012

— Withdrawal of a marketing authorization (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council)

Date of the decision

Name of the medicinal product

Holder of the marketing authorization

Number of the entry in the Community Register

Date of notification

24.10.2012

Rilonacept Regeneron

Regeneron UK Limited

40 Bank Street, E14 5DS London, United Kingdom

EU/1/09/582/001

26.10.2012

— Modification of a marketing authorization (Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted

Date of the decision

Name of the medicinal product

Holder of the marketing authorization

Number of the entry in the Community Register

Date of notification

10.10.2012

Acticam

Ecuphar NV

Legeweg 157-I, B-8020 Oostkamp, Belgïe

EU/2/08/088/004

12.10.2012

15.10.2012

Oxyglobin

OPK Biotech Netherlands BV

Teleportboulevard 140, 1043EJ Amsterdam, Nederland

EU/2/99/015/001-004

16.10.2012

23.10.2012

ProteqFlu

Merial

29 Avenue Tony Garnier, 69007 Lyon, France

EU/2/03/037/005

26.10.2012

24.10.2012

Pirsue

Pfizer Ltd

Ramsgate Road, Sandwich, Kent CT 13 9NJ, United Kingdom

EU/2/00/027/001-003

26.10.2012

25.10.2012

Dexdomitor

Orion Corporation

Orionintie 1, FIN-02200 Espoo, Suomi

EU/2/02/033/001-004

30.10.2012

25.10.2012

Posatex

Intervet International B.V.

Wim de Körverstraat 35, 5831 AN Boxmeer, Nederland

EU/2/08/081/001-003

29.10.2012

25.10.2012

Stronghold

Pfizer Ltd

Ramsgate Road, Sandwich, Kent CT 13 9NJ, United Kingdom

EU/2/99/014/001-012

29.10.2012

Improvac

Pfizer Limited

Ramsgate Road, Sandwich, Kent, CT13 9NJ, United Kingdom

EU/2/09/095/001-006

1.11.2012

29.10.2012

Loxicom

Norbrook Laboratories Limited

Station Works, Newry, Co. Down, BT35 6JP, United Kindgom

EU/2/08/090/001-028

31.10.2012

29.10.2012

Meloxidyl

CEVA SANTE ANIMALE

10 avenue de la Ballastière, 33500 Libourne, France

EU/2/06/070/009

31.10.2012

29.10.2012

Previcox

Merial

29 Avenue Tony Garnier, 69007 Lyon, France

EU/2/04/045/001-007

6.11.2012

29.10.2012

Procox

Bayer Animal Health GmbH

51368 Leverkusen, Deutschland

EU/2/11/123/001-002

2.11.2012

29.10.2012

RevitaCAM

Abbott Laboratories Limited

Abbott House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire SL6 4XE, UNITED KINGDOM

EU/2/12/138/001-003

31.10.2012

29.10.2012

Suvaxyn PCV

Pfizer Limited

Ramsgate Road, Sandwich, Kent CT13 9NJ United Kingdom

EU/2/09/099/001-006

1.11.2012

31.10.2012

PRILACTONE

CEVA SANTE ANIMALE

10 avenue de la Ballastière, 33500 Libourne, France

EU/2/07/074/001-009

6.11.2012

— Lift of suspension of a marketing authorization (Article 45 of Regulation (EC) No 726/2004 of the European Parliament and of the Council)

Date of the decision

Name of the medicinal product

Holder of the marketing authorization

Number of the entry in the Community Register

Date of notification

10.10.2012

Suvaxyn PCV

Pfizer Limited

Ramsgate Road, Sandwich, Kent CT13 9NJ United Kingdom

EU/2/09/099/001-006

12.10.2012

Anyone wishing to consult the public assessment report on the medicinal products in question and the decisions relating thereto is invited to contact:

The European Medicines Agency

7, Westferry Circus,

Canary Wharf

UK - LONDON E14 4H

(1) OJ L 136, 30.4.2004, p. 1.

Top